Correction to: Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI)
Thomas A. Fox, Valerie Massey, Charley Lever, Rachel Pearce, Arian Laurence, Sarah Grace, Filippo Oliviero, Sarita Workman, Andrew Symes, David M. Lowe, Valeria Fiaccadori, Rachael Hough, Susan Tadros, Siobhan O. Burns, Markus G. Seidel, Ben Carpenter, Emma C. Morris
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsImmunodeficiency and Autoimmune Disorders · Cytomegalovirus and herpesvirus research · Parvovirus B19 Infection Studies
Correction to: Journal of Clinical Immunology (2025) 45:64
10.1007/s10875-024-01854-y
In the published version, there was an erratum in the abstract:
- In the first sentence, the word “disease” was used twice:
Incorrect: “Allogeneic haematopoietic stem cell transplantation (alloHSCT) is safe and effective for adolescents and adults with inborn errors of immunity (IEI) with severe disease manifestations of their disease.”
Corrected: “Allogeneic haematopoietic stem cell transplantation (alloHSCT) is safe and effective for adolescents and adults with inborn errors of immunity (IEI) with severe manifestations of their disease.”
- In the last sentence of the abstract, there was a typographical error in the word “regarding.”
The original version has been corrected.